Please login to the form below

Not currently logged in
Email:
Password:

Fresenius

This page shows the latest Fresenius news and features for those working in and with pharma, biotech and healthcare.

Sanofi patent case win holds off generic rivals for key cancer drug

Sanofi patent case win holds off generic rivals for key cancer drug

Led by Fresenius Kabi, the cross-appeal sought to render another patent invalid on the grounds that the advance it covers is obvious. ... However, Fresenius’ legal team and the experts it presented failed to persuade the judges.

Latest news

More from news
Approximately 7 fully matching, plus 25 partially matching documents found.

Latest Intelligence

  • KAM 2.0 KAM 2.0

    The Fresenius Helios hospital group, based in Germany, recently acquired the Spanish hospital group Grupo Hospitalario Quirónsalud to become the largest hospital group in Europe.

  • Pharma deals continue to slide Pharma deals continue to slide

    For example, Fresenius’s acquisition of NxStage Medical (US), a home dialysis competitor, for $2bn is being financed with cash and debt. ... Even so the Fresenius shareholders do not seem worried as the share price remained much the same after the

  • Deal Watch - May 2017 Deal Watch - May 2017

    following an announcement as seen with BD and Cardinal Health.  It is encouraging, therefore, to see Fresenius’s share price increase by 2% following the announcement that its subsidiary Fresenius Kabi ... 6, 100. Akorn (US). Fresenius (DE). Company

  • Deal Watch May 2016 Deal Watch May 2016

    The presence of the CRL on the books however did not deter Vifor Fresenius Medical Care Renal Pharma's decision to license Rayaldee [a vitamin D prohormone treatment] from OPKO paying ... 293. OPKO Health/ Vifor Fresenius. Licence. Rayaldee in EP, CA,

  • Pharma deals in August 2015 Pharma deals in August 2015

    Collaboration. 219. Relypsa. Vifor Fresenius. Patiromer oral suspension in treating hyperkalemia.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Hikma appoints group scientific officer and global head of R&D Hikma appoints group scientific officer and global head of R&D

    He joins the pharma group from Fresenius Kabi, where he most recently led its US innovation and development centre. ... Prior to this, he served as chief scientific officer for Sabur Pharma, an oncology company that was acquired by Fresenius in 2008.

  • Galenica Group strengthens management team Galenica Group strengthens management team

    Currently chief executive of Vifor Fresenius Medical Care Renal Pharma (VFMCRP), Schulze (pictured right) will take up his new roles in May 2017 reporting to Etienne Jornod, executive chairman of the ... development at Fresenius Medical Care for North

  • Zytoprotec expands supervisory board Zytoprotec expands supervisory board

    He served as vice president of biosciences at Fresenius Medical Care, a medical devices and services firm, as well as its global scientific ambassador between 1996 and 2013.

  • Bartenbach adds to healthcare management team Bartenbach adds to healthcare management team

    Anja Treiber has worked with CSL Behring, Novo Nordisk, Fresenius Kabi and Merz Pharma. ... In the last two years, Treiber has focused on international pharma clients including CSL Behring, Novo Nordisk, Fresenius Kabi and Merz Pharma.

  • Par hires Antonio Pera as commercial head Par hires Antonio Pera as commercial head

    His positions prior to joining JHP include senior VP, supply chain management at AmerisourceBergen Corporation, and senior management positions at Fresenius Kabi Pharmaceuticals, Oakwood Laboratories and Bedford Laboratories.

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

  • Eoin McAtamney announced as Managing Director of Ashfield Ireland

    Eoin joins Ashfield from Fresenius Kabi in Ireland where he was National Sales Manager.

  • Blended Intelligence Blended Intelligence

    The premise of What We’re Made of for Fresenius Kabi was simple: adequate hydration is essential for a healthy life. ... This empathetic approach has provided a halo effect for Fresenius Kabi’s reputation, as well as inspiring the sales team to

  • Page & Page has been shortlisted for an award! Page & Page has been shortlisted for an award!

    Working with Fresenius Kabi, Page &Page has developed a campaign to ensure the challenge of hydration is properly understood and addressed within the NHS and amongst community stakeholders.

  • Fresenius Kabi Ltd.

    Fresenius Kabi is the leading European provider of clinical nutrition and infusion therapy offering a unique and comprehensive range of products and services for both hospital and home settings. ... Fresenius Kabi Ltd..

  • infill healthcare communication

    European Stroke Organisation. ESNCH. Fresenius. Gruenthal. International Association for the Study of Lung Cancer.

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Health

Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics